H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 87 Citations 28,041 306 World Ranking 483 National Ranking 290
Medicine D-index 93 Citations 30,864 387 World Ranking 5165 National Ranking 2903

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Virus
  • Internal medicine

Nelson L. Michael spends much of his time researching Virology, Immunology, Antibody, Virus and Vaccination. His Virology study incorporates themes from Epitope, Antigen and Immune system. His studies deal with areas such as HIV vaccine, AIDS Vaccines and AIDSVAX as well as Immunology.

The concepts of his AIDSVAX study are interwoven with issues in Peptide sequence and Case-control study. The Virus study combines topics in areas such as Polymerase chain reaction and Genotype. His Vaccination research is multidisciplinary, relying on both Internal medicine, Clinical trial, Acquired immunodeficiency syndrome, Immunogenicity and RV 144.

His most cited work include:

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand (2488 citations)
  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (1399 citations)
  • GENETIC ACCELERATION OF AIDS PROGRESSION BY A PROMOTER VARIANT OF CCR5 (433 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Virology, Immunology, Antibody, Immune system and Virus. His study in Virology is interdisciplinary in nature, drawing from both Epitope and HIV vaccine. As part of one scientific family, Nelson L. Michael deals mainly with the area of Immunology, narrowing it down to issues related to the Acquired immunodeficiency syndrome, and often Internal medicine.

His research integrates issues of RNA, Peripheral blood mononuclear cell and Genotype in his study of Virus. His Viral load research incorporates themes from Viremia, CD8 and Viral replication. He has included themes like Placebo, Clinical trial and Immunogenicity in his Vaccination study.

He most often published in these fields:

  • Virology (58.35%)
  • Immunology (48.81%)
  • Antibody (31.24%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (58.35%)
  • Immunology (48.81%)
  • Immune system (19.74%)

In recent papers he was focusing on the following fields of study:

Nelson L. Michael mainly investigates Virology, Immunology, Immune system, Antibody and Vaccination. In Virology, Nelson L. Michael works on issues like Epitope, which are connected to Antigen-presenting cell. His study in T cell, Viral load, Immunogenicity, Viral replication and Immunity falls within the category of Immunology.

Nelson L. Michael has included themes like Cytotoxic T cell, Viral rebound and Antigen in his Immune system study. Antibody and Phagocytosis are frequently intertwined in his study. His research integrates issues of HIV vaccine, Canarypox, Transcriptome and Zika virus in his study of Vaccination.

Between 2017 and 2021, his most popular works were:

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (140 citations)
  • Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. (137 citations)
  • Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. (120 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Internal medicine

Nelson L. Michael mostly deals with Immunology, Immune system, Virology, Clinical trial and Vaccination. As part of his studies on Immunology, Nelson L. Michael often connects relevant subjects like Transcriptome. His studies examine the connections between Immune system and genetics, as well as such issues in Antibody, with regards to Lineage.

The Viremia research Nelson L. Michael does as part of his general Virology study is frequently linked to other disciplines of science, such as Extramural, therefore creating a link between diverse domains of science. His work investigates the relationship between Clinical trial and topics such as Adverse effect that intersect with problems in Randomized controlled trial. Nelson L. Michael works mostly in the field of Vaccination, limiting it down to concerns involving HIV vaccine and, occasionally, MF59, Cytotoxic T cell and Regimen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal.
The New England Journal of Medicine (2009)

3330 Citations

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)

1662 Citations

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

N. L. Michael;G. Chang;L. G. Louie;J. R. Mascola.
Nature Medicine (1997)

579 Citations

GENETIC ACCELERATION OF AIDS PROGRESSION BY A PROMOTER VARIANT OF CCR5

Maureen P. Martin;Michael Dean;Michael W. Smith;Cheryl Winkler.
Science (1998)

528 Citations

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
Nature (2012)

467 Citations

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

James B. Whitney;Alison L. Hill;Srisowmya Sanisetty;Pablo Penaloza-MacMaster.
Nature (2014)

456 Citations

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra.
Nature (2012)

432 Citations

Vaccine protection against Zika virus from Brazil

Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto.
Nature (2016)

429 Citations

Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

Victor Valcour;Thep Chalermchai;Napapon Sailasuta;Mary Marovich.
The Journal of Infectious Diseases (2012)

410 Citations

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Peter Abbink;Rafael A. Larocca;Rafael A. De La Barrera;Christine A. Bricault.
Science (2016)

394 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nelson L. Michael

David C. Montefiori

David C. Montefiori

Duke University

Publications: 310

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 250

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 213

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 189

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 148

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 134

Peter B. Gilbert

Peter B. Gilbert

Fred Hutchinson Cancer Research Center

Publications: 130

Galit Alter

Galit Alter

Ragon Institute of MGH, MIT and Harvard

Publications: 122

Guido Ferrari

Guido Ferrari

Duke University

Publications: 121

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 117

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 116

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 115

M. Juliana McElrath

M. Juliana McElrath

Fred Hutchinson Cancer Research Center

Publications: 113

Susan Zolla-Pazner

Susan Zolla-Pazner

Icahn School of Medicine at Mount Sinai

Publications: 112

Mary Carrington

Mary Carrington

Ragon Institute of MGH, MIT and Harvard

Publications: 105

Merlin L. Robb

Merlin L. Robb

Walter Reed Army Institute of Research

Publications: 103

Something went wrong. Please try again later.